Report an error

Spotted something inaccurate in “SGLT2 Inhibitors Show Lower Joint Replacement Risk Than Other Diabetes Drugs”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.